A 52-year-old man presents his primary care physician for follow-up. 3 months ago, he was diagnosed with type 2 diabetes mellitus and metformin was started. Today, his HbA1C is 7.9%. The physician decides to add pioglitazone for better control of hyperglycemia. Which of the following is a contraindication to pioglitazone therapy?
Q52
A 40-year-old male in West Virginia presents to the emergency room complaining that his vision has deteriorated within the past several hours to the point that he can no longer see. He explains that some acquaintances sold him some homemade liquor and stated that it was pure as it burned with a "yellow flame." Which of the following if administered immediately after drinking the liquor would have saved his vision?
Q53
A 32-year-old woman presents to the clinic for routine follow-up. She recently discovered that she is pregnant and is worried about taking medications throughout her pregnancy. She has a history of hypothyroidism and takes levothyroxine daily. Her vital signs are unremarkable. Her physical exam is consistent with the estimated 11-week gestation time. Which of the following statements regarding levothyroxine use during pregnancy is correct?
Q54
A 61-year-old female with a history of breast cancer currently on chemotherapy is brought by her husband to her oncologist for evaluation of a tremor. She reports that she developed a hand tremor approximately six months ago, prior to the start of her chemotherapy. The tremor is worse at rest and decreases with purposeful movement. She has experienced significant nausea and diarrhea since the start of her chemotherapy. Her past medical history is also notable for diabetes and hypertension treated with metformin and lisinopril, respectively. She takes no other medications. On examination, there is a tremor in the patient’s left hand. Muscle tone is increased in the upper extremities. Gait examination reveals difficulty initiating gait and shortened steps. Which of the following medications is contraindicated in the management of this patient’s nausea and diarrhea?
Q55
A 65-year-old man with a history of myocardial infarction is admitted to the hospital for treatment of atrial fibrillation with rapid ventricular response. He is 180 cm (5 ft 11 in) tall and weighs 80 kg (173 lb). He is given an intravenous bolus of 150 mg of amiodarone. After 20 minutes, the amiodarone plasma concentration is 2.5 mcg/mL. Amiodarone distributes in the body within minutes, and its elimination half-life after intravenous administration is 30 days. Which of the following values is closest to the volume of distribution of the administered drug?
Q56
A 10-year-old boy comes to the physician for a follow-up examination. He was diagnosed with asthma one year ago and uses an albuterol inhaler as needed. His mother reports that he has had shortness of breath on exertion and a dry cough 3–4 times per week over the past month. Pulmonary examination shows expiratory wheezing in all lung fields. Treatment with low-dose inhaled mometasone is initiated. Which of the following recommendations is most appropriate to prevent complications from this treatment?
Q57
A 40-year-old man is bitten by a copperhead snake, and he is successfully treated with sheep hyperimmune Fab antivenom. Six days later, the patient develops an itchy abdominal rash and re-presents to the emergency department for medical care. He works as a park ranger. His medical history is significant for gout, hypertension, hypercholesterolemia, diabetes mellitus type II, and multiple basal cell carcinomas on his face and neck. He currently smokes 1 pack of cigarettes per day, drinks a 6-pack of beer per day, and currently denies any illicit drug use. His vital signs include: temperature 40.0°C (104.0°F), blood pressure 126/74 mm Hg, heart rate 111/min, and respiratory rate 23/min. On physical examination, his gait is limited by diffuse arthralgias, and he has clear breath sounds bilaterally and normal heart sounds. There is also a pruritic abdominal serpiginous macular rash which has spread to involve the back, upper trunk, and extremities. Of the following options, which best describes the mechanism of his reaction?
Q58
A 9-year-old boy with cerebral palsy is about to undergo a femoral osteotomy. An intravenous catheter needs to be placed; however, given prior experience the boy is extremely anxious and does not want to be stuck with a needle while awake. The decision is made to administer appropriate anesthesia by mask first before any other procedures are performed. An inhalation agent that would anesthetize most quickly has which of the following characteristics?
Q59
A 53-year-old woman presents to a medical clinic complaining of diarrhea. She also has episodes during which her face becomes red and she becomes short of breath. These symptoms have been ongoing for the past few months. Five years ago she had an appendectomy. The medical history is otherwise not significant. On physical examination, her vital signs are normal. Wheezing is heard at the bases of the lungs bilaterally. A CT scan reveals multiple small nodules in the liver. A 24-hr urine collection reveals increased 5-hydroxyindoleacetic acid (5-HIAA). Which of the following is the next best step in the management of the patient?
Q60
A 54-year-old man presents to the office for consultation regarding the results of recent laboratory studies. Medical history includes stage 3 chronic kidney disease, diabetes mellitus type 2, and hypertension, which is currently well controlled with lisinopril and furosemide. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, heart rate 87/min, and respiratory rate 17/min. On physical examination, the heart sounds show a grade 3/6 holosystolic murmur heard best at the left upper sternal border, breath sounds are clear, no abnormal abdominal findings, and 2+ pedal edema of the bilateral lower extremities up to the knee. The patient has a 23-pack-year history of cigarette smoking. The results of the laboratory studies of serum include the following:
ALT 20 U/L
AST 19 U/L
Total cholesterol 249 mg/dL
LDL 160 mg/dL
HDL 41 mg/dL
Triglycerides 101 mg/dL
Initiation of therapy with which of the following agents is most appropriate for the management of hyperlipidemia in this patient?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 51: A 52-year-old man presents his primary care physician for follow-up. 3 months ago, he was diagnosed with type 2 diabetes mellitus and metformin was started. Today, his HbA1C is 7.9%. The physician decides to add pioglitazone for better control of hyperglycemia. Which of the following is a contraindication to pioglitazone therapy?
A. Pancreatitis
B. Renal impairment
C. Sulfa allergy
D. Genital mycotic infection
E. History of bladder cancer (Correct Answer)
Explanation: ***History of bladder cancer***
- **Pioglitazone** has been associated with an increased risk of **bladder cancer**, and therefore, it is **contraindicated** in patients with a history of bladder cancer or active bladder cancer.
- The risk appears to be dose and duration-dependent, making prior bladder cancer a significant safety concern.
- **Note**: The most critical contraindication to pioglitazone is **heart failure (NYHA Class III-IV)**, which carries an FDA black box warning due to fluid retention and worsening heart failure. Among the options provided, history of bladder cancer is the documented contraindication.
*Pancreatitis*
- While some diabetes medications, like **GLP-1 receptor agonists** and **DPP-4 inhibitors**, have been linked to pancreatitis, **pioglitazone (a thiazolidinedione)** is not directly associated with this condition to the extent of being a contraindication.
- The primary concerns with pioglitazone are fluid retention, heart failure, and bladder cancer risk—not pancreatitis.
*Renal impairment*
- **Pioglitazone** is primarily metabolized in the **liver**, and its elimination is not significantly dependent on renal function.
- Therefore, it can generally be used in patients with renal impairment, unlike some other antidiabetic drugs (e.g., metformin, SGLT2 inhibitors at advanced stages).
- No dose adjustment is required for renal impairment.
*Sulfa allergy*
- **Pioglitazone** is not a **sulfonamide derivative**, unlike sulfonylureas (e.g., glyburide, glipizide).
- Therefore, a sulfa allergy is not a contraindication for pioglitazone use.
*Genital mycotic infection*
- **Genital mycotic infections** are a common side effect of **SGLT2 inhibitors** (e.g., empagliflozin, canagliflozin) due to increased urinary glucose excretion.
- Pioglitazone does not work via this mechanism and is not specifically contraindicated for patients with a history of these infections.
Question 52: A 40-year-old male in West Virginia presents to the emergency room complaining that his vision has deteriorated within the past several hours to the point that he can no longer see. He explains that some acquaintances sold him some homemade liquor and stated that it was pure as it burned with a "yellow flame." Which of the following if administered immediately after drinking the liquor would have saved his vision?
A. Methylene blue
B. Succimer
C. Ethanol (Correct Answer)
D. Amyl nitrite
E. Atropine
Explanation: ***Ethanol***
- The patient's symptoms (sudden vision loss) and history (homemade liquor burning with a "yellow flame") are highly suggestive of **methanol poisoning**. Methanol is metabolized by **alcohol dehydrogenase (ADH)** to **formaldehyde**, then to **formic acid**, which is highly toxic to the optic nerve and retina, causing blindness.
- **Ethanol** acts as a competitive substrate for **ADH**, which has higher affinity for ethanol than methanol. By administering ethanol, the metabolism of methanol to toxic metabolites is blocked, allowing time for methanol to be excreted unchanged via the kidneys, thus preventing further damage.
- **Note**: While **fomepizole** (4-methylpyrazole) is now the preferred first-line ADH inhibitor due to fewer side effects, **ethanol remains an acceptable alternative** when fomepizole is unavailable, particularly in emergency settings or rural areas.
*Methylene blue*
- **Methylene blue** is used in the treatment of **methemoglobinemia**, a condition where the iron in hemoglobin is oxidized to the ferric state (Fe³⁺), reducing oxygen-carrying capacity.
- This patient's symptoms are not consistent with methemoglobinemia (which presents with cyanosis unresponsive to oxygen), and methylene blue would not address the **methanol toxicity**.
*Succimer*
- **Succimer** (DMSA) is a chelating agent primarily used for the treatment of **lead poisoning** and other heavy metal toxicities (mercury, arsenic).
- It would not be effective in treating methanol poisoning, which is a metabolic toxicity requiring competitive enzyme inhibition, not chelation.
*Amyl nitrite*
- **Amyl nitrite** is used in the treatment of **cyanide poisoning** by inducing methemoglobinemia, which then binds cyanide ions.
- Its mechanism of action and indications are unrelated to methanol poisoning, which involves toxic organic acid accumulation rather than cellular respiration blockade.
*Atropine*
- **Atropine** is an anticholinergic medication used to treat **organophosphate/carbamate poisoning** (by blocking excess acetylcholine) and symptomatic bradycardia.
- It would have no therapeutic effect on methanol toxicity and is unrelated to alcohol dehydrogenase or formic acid metabolism.
Question 53: A 32-year-old woman presents to the clinic for routine follow-up. She recently discovered that she is pregnant and is worried about taking medications throughout her pregnancy. She has a history of hypothyroidism and takes levothyroxine daily. Her vital signs are unremarkable. Her physical exam is consistent with the estimated 11-week gestation time. Which of the following statements regarding levothyroxine use during pregnancy is correct?
A. Well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters. (Correct Answer)
B. Levothyroxine use in pregnancy is contraindicated, and its use should be discontinued.
C. Levothyroxine can be safely used in the first trimester of pregnancy but should be discontinued in the second and third trimesters.
D. Pregnant women will need to reduce the dose of levothyroxine to prevent congenital malformations.
E. Animal studies have shown an adverse effect to the fetus, but there are no adequate and well-controlled studies in humans.
Explanation: ***Well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters.***
- Many studies indicate that **levothyroxine** is safe and essential for managing **maternal hypothyroidism** throughout all trimesters of pregnancy.
- Adequate maternal thyroid hormone levels are crucial for **fetal neurological development** and **preventing complications** in pregnancy.
- **Levothyroxine is considered safe** throughout pregnancy with extensive human data supporting its use.
*Levothyroxine use in pregnancy is contraindicated, and its use should be discontinued.*
- **Discontinuing levothyroxine** during pregnancy in a hypothyroid patient would lead to **maternal and fetal hypothyroidism**, causing severe adverse outcomes.
- **Hypothyroidism during pregnancy** is associated with increased risks of **preeclampsia**, **gestational hypertension**, **preterm birth**, and impaired fetal cognitive development.
*Levothyroxine can be safely used in the first trimester of pregnancy but should be discontinued in the second and third trimesters.*
- **Thyroid hormone requirements typically increase** throughout pregnancy, often necessitating a higher dose of levothyroxine rather than discontinuation in later trimesters.
- Maintaining **euthyroid state** is important throughout the entire pregnancy to ensure optimal fetal growth and development.
*Pregnant women will need to reduce the dose of levothyroxine to prevent congenital malformations.*
- Pregnant women with hypothyroidism most often require an **increase in their levothyroxine dosage** (typically 25-50% higher) to maintain euthyroidism due to increased thyroid hormone demands.
- **Hypothyroidism**, not appropriate levothyroxine doses, is associated with adverse pregnancy outcomes and potential fetal malformations.
*Animal studies have shown an adverse effect to the fetus, but there are no adequate and well-controlled studies in humans.*
- This statement does not apply to levothyroxine, which has **extensive human data** demonstrating safety in pregnancy.
- **Well-controlled studies in pregnant women** have established the safety and necessity of levothyroxine during pregnancy in hypothyroid women.
Question 54: A 61-year-old female with a history of breast cancer currently on chemotherapy is brought by her husband to her oncologist for evaluation of a tremor. She reports that she developed a hand tremor approximately six months ago, prior to the start of her chemotherapy. The tremor is worse at rest and decreases with purposeful movement. She has experienced significant nausea and diarrhea since the start of her chemotherapy. Her past medical history is also notable for diabetes and hypertension treated with metformin and lisinopril, respectively. She takes no other medications. On examination, there is a tremor in the patient’s left hand. Muscle tone is increased in the upper extremities. Gait examination reveals difficulty initiating gait and shortened steps. Which of the following medications is contraindicated in the management of this patient’s nausea and diarrhea?
A. Diphenhydramine
B. Ondansetron
C. Metoclopramide (Correct Answer)
D. Loperamide
E. Benztropine
Explanation: ***Metoclopramide***
- This patient presents with symptoms consistent with **Parkinson’s disease** (resting tremor, rigidity, bradykinesia indicated by gait initiation difficulty and shortened steps). **Metoclopramide** is a dopamine receptor antagonist that can worsen **extrapyramidal symptoms** and is therefore contraindicated.
- While metoclopramide is used to treat nausea and vomiting, its **dopamine blocking effects** on the central nervous system would exacerbate the patient's existing Parkinsonian symptoms.
*Diphenhydramine*
- **Diphenhydramine** is an antihistamine with anticholinergic properties that can be used to treat nausea and can also reduce **tremor**, making it potentially beneficial rather than contraindicated.
- Its anticholinergic effects can actually help alleviate some Parkinsonian symptoms, particularly tremor, though it is not a primary treatment.
*Ondansetron*
- **Ondansetron** is a **5-HT3 receptor antagonist** and is a first-line antiemetic for chemotherapy-induced nausea and vomiting. It does not affect dopamine pathways.
- It would not worsen this patient's Parkinsonian symptoms, making it a safe choice for nausea management.
*Loperamide*
- **Loperamide** is an **opioid receptor agonist** used to treat diarrhea. It acts on opioid receptors in the gut to slow motility.
- It does not have known interactions that would worsen Parkinson's disease or its symptoms.
*Benztropine*
- **Benztropine** is an **anticholinergic medication** used to treat Parkinson's disease symptoms, particularly tremor and rigidity.
- It would be *therapeutic* for the patient's Parkinsonian symptoms, not contraindicated.
Question 55: A 65-year-old man with a history of myocardial infarction is admitted to the hospital for treatment of atrial fibrillation with rapid ventricular response. He is 180 cm (5 ft 11 in) tall and weighs 80 kg (173 lb). He is given an intravenous bolus of 150 mg of amiodarone. After 20 minutes, the amiodarone plasma concentration is 2.5 mcg/mL. Amiodarone distributes in the body within minutes, and its elimination half-life after intravenous administration is 30 days. Which of the following values is closest to the volume of distribution of the administered drug?
A. 60 L (Correct Answer)
B. 80 L
C. 150 L
D. 17 L
E. 10 L
Explanation: ***60 L***
- The **volume of distribution (Vd)** is calculated using the formula: **Vd = Dose / Plasma Concentration**.
- Given: Dose = 150 mg (150,000 mcg), Plasma concentration = 2.5 mcg/mL
- Calculation: Vd = 150,000 mcg / 2.5 mcg/mL = 60,000 mL = **60 L**
- Note: This calculation represents a simplified scenario. In clinical practice, amiodarone has an extremely large volume of distribution (60-100 L/kg or ~4,800-8,000 L in this patient) due to extensive tissue distribution, but the question tests the ability to apply the basic pharmacokinetic formula.
*80 L*
- This value would result if the plasma concentration were 1.875 mcg/mL (150,000 mcg / 80,000 mL), not the given 2.5 mcg/mL.
- This represents a common calculation error when working with pharmacokinetic parameters.
*150 L*
- This value would require a plasma concentration of 1 mcg/mL (150,000 mcg / 150,000 mL), which is lower than the measured 2.5 mcg/mL.
- This error might occur if the dose value were confused with the volume of distribution.
*17 L*
- This value would be obtained with a plasma concentration of approximately 8.8 mcg/mL (150,000 mcg / 17,000 mL), significantly higher than the measured 2.5 mcg/mL.
- This represents a significant underestimation of Vd and would suggest limited drug distribution.
*10 L*
- This value would require a plasma concentration of 15 mcg/mL (150,000 mcg / 10,000 mL), which is 6-fold higher than the given 2.5 mcg/mL.
- Such a small Vd would suggest drug confined primarily to plasma, which is inappropriate for lipophilic drugs with extensive tissue distribution.
Question 56: A 10-year-old boy comes to the physician for a follow-up examination. He was diagnosed with asthma one year ago and uses an albuterol inhaler as needed. His mother reports that he has had shortness of breath on exertion and a dry cough 3–4 times per week over the past month. Pulmonary examination shows expiratory wheezing in all lung fields. Treatment with low-dose inhaled mometasone is initiated. Which of the following recommendations is most appropriate to prevent complications from this treatment?
A. Oral rinsing after medication administration (Correct Answer)
B. Pantoprazole use prior to meals
C. Weight-bearing exercise three times weekly
D. Trimethoprim-sulfamethoxazole use three times weekly
E. Minimizing use of a spacer
Explanation: ***Oral rinsing after medication administration***
- **Oral rinsing** after using an inhaled corticosteroid like mometasone helps to remove medication residue from the mouth and throat.
- This significantly reduces the risk of local side effects such as **oral candidiasis (thrush)** and **dysphonia**.
*Pantoprazole use prior to meals*
- **Pantoprazole** is a proton pump inhibitor used to treat acid reflux or GERD.
- While GERD can sometimes exacerbate asthma, there is no direct link between inhaled mometasone use and the need for prophylactic pantoprazole.
*Weight-bearing exercise three times weekly*
- **Weight-bearing exercises** are beneficial for bone health and overall fitness, particularly important for long-term oral corticosteroid use which can cause skeletal complications.
- However, inhaled corticosteroids like mometasone have minimal systemic absorption and therefore have a negligible effect on bone mineral density in typical therapeutic doses.
*Trimethoprim-sulfamethoxazole use three times weekly*
- **Trimethoprim-sulfamethoxazole** is an antibiotic used for preventing or treating bacterial infections, particularly in immunocompromised individuals.
- Inhaled corticosteroids do not typically cause significant systemic immunosuppression requiring prophylactic antibiotics.
*Minimizing use of a spacer*
- A **spacer** is a device used with metered-dose inhalers that helps improve drug delivery to the lungs and reduces deposition in the oropharynx.
- Maximizing, not minimizing, the use of a spacer is recommended to enhance efficacy and reduce local side effects of inhaled corticosteroids.
Question 57: A 40-year-old man is bitten by a copperhead snake, and he is successfully treated with sheep hyperimmune Fab antivenom. Six days later, the patient develops an itchy abdominal rash and re-presents to the emergency department for medical care. He works as a park ranger. His medical history is significant for gout, hypertension, hypercholesterolemia, diabetes mellitus type II, and multiple basal cell carcinomas on his face and neck. He currently smokes 1 pack of cigarettes per day, drinks a 6-pack of beer per day, and currently denies any illicit drug use. His vital signs include: temperature 40.0°C (104.0°F), blood pressure 126/74 mm Hg, heart rate 111/min, and respiratory rate 23/min. On physical examination, his gait is limited by diffuse arthralgias, and he has clear breath sounds bilaterally and normal heart sounds. There is also a pruritic abdominal serpiginous macular rash which has spread to involve the back, upper trunk, and extremities. Of the following options, which best describes the mechanism of his reaction?
A. Type IV–cell-mediated (delayed) hypersensitivity reaction
B. Type I–anaphylactic hypersensitivity reaction
C. Type II–cytotoxic hypersensitivity reaction
D. Type III–immune complex-mediated hypersensitivity reaction (Correct Answer)
E. Type I and IV–mixed anaphylactic and cell-mediated hypersensitivity reactions
Explanation: ***Type III–immune complex-mediated hypersensitivity reaction***
- The patient's symptoms (fever, rash, arthralgias) developing several days after receiving **sheep hyperimmune Fab antivenom** are classic for **serum sickness**, a type III hypersensitivity reaction.
- This reaction occurs when **antibody-antigen complexes** form and deposit in tissues, activating complement and causing inflammation.
*Type IV–cell-mediated (delayed) hypersensitivity reaction*
- This type of reaction is mediated by **T-cells** and typically involves a delayed response (24-72 hours), seen in reactions like **contact dermatitis** or PPD tests, but does not usually present with fever and widespread rash as described.
- While there is a delayed component, the systemic symptoms of fever and arthralgias point away from a purely cell-mediated response.
*Type I–anaphylactic hypersensitivity reaction*
- Type I reactions are **IgE-mediated**, rapid-onset reactions (minutes to hours) characterized by **urticaria**, angioedema, bronchospasm, and hypotension.
- The delayed onset of symptoms (six days later) rules out an acute anaphylactic reaction.
*Type II–cytotoxic hypersensitivity reaction*
- Type II reactions involve **antibodies directed against antigens on cell surfaces**, leading to cell destruction (e.g., **hemolytic transfusion reactions**, autoimmune hemolytic anemia).
- The patient's presentation with a widespread rash and arthralgias is not consistent with cell-specific destruction.
*Type I and IV–mixed anaphylactic and cell-mediated hypersensitivity reactions*
- While mixed reactions can occur, the specific combination of symptoms and the delayed onset strongly favor a single, well-defined mechanism: **Type III serum sickness**.
- There is no clinical evidence to support an acute IgE-mediated (Type I) component or a primary cell-mediated (Type IV) process as the main cause of the widespread systemic illness.
Question 58: A 9-year-old boy with cerebral palsy is about to undergo a femoral osteotomy. An intravenous catheter needs to be placed; however, given prior experience the boy is extremely anxious and does not want to be stuck with a needle while awake. The decision is made to administer appropriate anesthesia by mask first before any other procedures are performed. An inhalation agent that would anesthetize most quickly has which of the following characteristics?
A. Low blood solubility (Correct Answer)
B. High blood solubility
C. High cerebrospinal fluid solubility
D. Low lipid solubility
E. High lipid solubility
Explanation: ***Low blood solubility***
- An inhalation agent with **low blood solubility** has a fast **onset of action** because less anesthetic dissolves in the blood, leading to a quicker rise in the partial pressure of the anesthetic gas in the brain.
- This rapid equilibration between the inhaled gas and the brain allows for a quick induction of anesthesia, which is desirable for anxious pediatric patients.
*High blood solubility*
- An inhalation agent with **high blood solubility** has a slow **onset of action** because a large amount of the anesthetic dissolves in the blood before equilibrium with the brain is achieved.
- This delays the rise in brain partial pressure of the anesthetic, prolonging the induction period.
*High cerebrospinal fluid solubility*
- While cerebrospinal fluid (CSF) solubility can affect the duration of action and recovery from anesthesia by influencing the brain's internal environment, it does not primarily dictate the **speed of initial induction**.
- The critical factor for rapid induction is the rate at which the anesthetic reaches the brain itself, primarily governed by blood-brain partial pressure gradients.
*Low lipid solubility*
- Most inhalation agents exert their primary effects by dissolving in the **lipid bilayers** of neuronal membranes in the brain to alter their function.
- A low lipid solubility would mean that the agent would have difficulty crossing the **blood-brain barrier** and partitioning into neuronal membranes, leading to poor anesthetic efficacy.
*High lipid solubility*
- While **high lipid solubility** is important for an anesthetic agent to effectively cross the blood-brain barrier and partition into the brain tissue, it does not directly correlate with a **fast onset of action** for induction.
- An agent with high lipid solubility but also high blood solubility would still have a slow onset because it would be extensively taken up by the blood before reaching the brain.
Question 59: A 53-year-old woman presents to a medical clinic complaining of diarrhea. She also has episodes during which her face becomes red and she becomes short of breath. These symptoms have been ongoing for the past few months. Five years ago she had an appendectomy. The medical history is otherwise not significant. On physical examination, her vital signs are normal. Wheezing is heard at the bases of the lungs bilaterally. A CT scan reveals multiple small nodules in the liver. A 24-hr urine collection reveals increased 5-hydroxyindoleacetic acid (5-HIAA). Which of the following is the next best step in the management of the patient?
A. Explain to the patient that this condition would resolve spontaneously
B. Start the patient on propranolol
C. Perform a liver nodule excision with wide margins
D. Start the patient on octreotide to manage the symptoms (Correct Answer)
E. Test for serum chromogranin A (CgA)
Explanation: ***Start the patient on octreotide to manage the symptoms***
- The patient's symptoms (diarrhea, facial redness/flushing, shortness of breath/wheezing), elevated **5-HIAA**, and liver nodules are classic for **carcinoid syndrome**, likely from a neuroendocrine tumor that has metastasized to the liver.
- **Octreotide**, a somatostatin analog, is the mainstay of treatment for symptomatic control in carcinoid syndrome by inhibiting the release of peptide hormones, including serotonin, from neuroendocrine tumors.
*Explain to the patient that this condition would resolve spontaneously*
- **Carcinoid syndrome** due to metastatic disease, as indicated by liver nodules and elevated 5-HIAA, is a progressive condition and **does not resolve spontaneously**.
- Without treatment, symptoms will likely worsen, and the disease can lead to significant morbidity and mortality, particularly due to **carcinoid heart disease**.
*Start the patient on propranolol*
- **Propranolol** is a non-selective beta-blocker that could potentially worsen **bronchospasm** (indicated by wheezing) in patients with carcinoid syndrome, as serotonin can cause bronchial constriction.
- While beta-blockers might be used for specific cardiac manifestations of carcinoid syndrome, they are not the initial or primary symptomatic treatment for the constellation of symptoms presented.
*Perform a liver nodule excision with wide margins*
- While surgical resection of liver metastases can be considered in some cases, especially for **debulking** or disease control, it is not the *next best step* for immediate **symptom management** in a patient with active carcinoid syndrome.
- The primary goal at this stage is to control the hormonal symptoms, for which octreotide is highly effective. Excision would be a later consideration, often after initial medical stabilization.
*Test for serum chromogranin A (CgA)*
- While **serum chromogranin A (CgA)** is a useful tumor marker for **neuroendocrine tumors**, the diagnosis of carcinoid syndrome is already strongly established by the clinical picture, elevated 5-HIAA, and liver metastases.
- Obtaining CgA would confirm the diagnosis but would not be the *next best step* for immediate management of the patient's severe symptoms. **Symptomatic control** is the priority.
Question 60: A 54-year-old man presents to the office for consultation regarding the results of recent laboratory studies. Medical history includes stage 3 chronic kidney disease, diabetes mellitus type 2, and hypertension, which is currently well controlled with lisinopril and furosemide. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, heart rate 87/min, and respiratory rate 17/min. On physical examination, the heart sounds show a grade 3/6 holosystolic murmur heard best at the left upper sternal border, breath sounds are clear, no abnormal abdominal findings, and 2+ pedal edema of the bilateral lower extremities up to the knee. The patient has a 23-pack-year history of cigarette smoking. The results of the laboratory studies of serum include the following:
ALT 20 U/L
AST 19 U/L
Total cholesterol 249 mg/dL
LDL 160 mg/dL
HDL 41 mg/dL
Triglycerides 101 mg/dL
Initiation of therapy with which of the following agents is most appropriate for the management of hyperlipidemia in this patient?
A. Simvastatin (Correct Answer)
B. Fenofibrate
C. Fish oil
D. Ezetimibe
E. Niacin
Explanation: ***Simvastatin***
- This patient has **diabetes mellitus type 2**, a **history of smoking**, and **HTN**, which are all significant risk factors for **atherosclerotic cardiovascular disease (ASCVD)**. High cholesterol levels (total cholesterol 249 mg/dL, LDL 160 mg/dL) necessitate **statin therapy** for ASCVD risk reduction.
- **Simvastatin** is a **moderate-intensity statin** appropriate for reducing ASCVD risk by lowering LDL cholesterol. Despite existing **CKD stage 3**, simvastatin can be safely initiated at an appropriate dosage, as it's generally well-tolerated and effective even with moderate renal impairment.
- Among the options provided, simvastatin is the most appropriate **first-line therapy** for this patient's elevated LDL cholesterol.
*Fenofibrate*
- Fenofibrate is primarily used to lower **triglycerides** and to a lesser extent, increase HDL. This patient's triglyceride level (101 mg/dL) is within the normal range.
- While fenofibrate can also affect cholesterol, the primary goal here is significant **LDL reduction** in a high-risk patient, for which statins are first-line therapy.
*Fish oil*
- **Fish oil** supplements, rich in **omega-3 fatty acids**, are primarily used to lower significantly elevated **triglyceride levels** (typically >500 mg/dL).
- This patient's triglyceride level is normal (101 mg/dL), and fish oil is not indicated as a primary therapy for **LDL reduction** in high-risk patients.
*Ezetimibe*
- **Ezetimibe** is a cholesterol absorption inhibitor that primarily lowers LDL-C. It is typically used as an **add-on therapy** when statins alone do not achieve target LDL-C levels or in patients who are **statin-intolerant**.
- Given that a statin has not yet been initiated, ezetimibe would not be the first-line choice for initial management in this high-risk patient.
*Niacin*
- **Niacin** (nicotinic acid) can lower LDL cholesterol and triglycerides while raising HDL, but it is associated with significant side effects such as **flushing** and **hepatotoxicity**.
- Its use has declined due to lack of evidence showing improved cardiovascular outcomes when added to statin therapy, and it is not considered first-line for **ASCVD prevention**.